{
    "organizations": [],
    "uuid": "9c0140c0c58136999cfbe87670975dacef62f704",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-synthetic-biologics-cash-equivalen/brief-synthetic-biologics-cash-equivalents-on-dec-31-2017-17-1-mln-idUSASB0C6XJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Synthetic Biologics Cash Equivalents On Dec 31, 2017 $17.1 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 22 (Reuters) - Synthetic Biologics Inc:\n* SYNTHETIC BIOLOGICS REPORTS 2017 YEAR END OPERATIONAL HIGHLIGHTS AND FINANCIAL RESULTS\n* SYNTHETIC BIOLOGICS INC - CASH AND CASH EQUIVALENTS ON DEC 31, 2017 WERE $17.1 MILLION, A DECREASE OF $2.0 MILLION FROM DEC 31, 2016. Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-22T20:11:00.000+02:00",
    "crawled": "2018-02-23T15:46:01.092+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "synthetic",
        "biologics",
        "inc",
        "synthetic",
        "biologics",
        "report",
        "year",
        "end",
        "operational",
        "highlight",
        "financial",
        "result",
        "synthetic",
        "biologics",
        "inc",
        "cash",
        "cash",
        "equivalent",
        "dec",
        "million",
        "decrease",
        "million",
        "dec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}